Advanced Filter

Filter by Group

Filter by Market Availability

Displaying all 3 drugs
A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. Having been developed in the 1980s by GlaxoSmithKline and approved by the US FDA since January 1991, ondansetron has...
Approved
Matched Products: … BRAUN SOLUTION FOR INJECTION OR INFUSION 2 MG/ML ... ONRON 8 SOLUTION FOR INJECTION OR INFUSION 2 MG/ML ... ONRON 4 SOLUTION FOR INJECTION OR INFUSION 2 MG/ML …
Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor...
Approved
Vet approved
Matched Description: … It was FDA approved in 1970, and from there, it has been used as an anesthetic for children or patients …
Midazolam is a short-acting hypnotic-sedative drug with anxiolytic, muscle relaxant, anticonvulsant, sedative, hypnotic, and amnesic properties. It belongs to a class of drugs called benzodiazepines. This drug is unique from others in this class due to its rapid onset of effects and short duration of action. Midazolam is available by...
Approved
Illicit
Displaying all 3 drugs